Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Heparin for Thromboprophylaxis in Major Thoracic Surgery
NCT02940444Phase 2Unknown
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jun 2016
- Primary completion
- Jun 2018
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of heparin in thromboembolism (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Intraoperative Bleeding Volume, Chest Tube Drainage Volume and 6 more. Status: unknown.
02
Drugs
heparin
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02940444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02940444.